Anti-YTHDF2 Recombinant Monoclonal

Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
A700-297-T 20 µl (2 blots) -

2 - 8 Werktage*

172,00 €
A700-297 100 µl (10 blots) -

2 - 8 Werktage*

652,00 €
521,60 €
 
Protein function: Specifically recognizes and binds N6-methyladenosine (m6A)- containing RNAs,... mehr
Produktinformationen "Anti-YTHDF2 Recombinant Monoclonal"
Protein function: Specifically recognizes and binds N6-methyladenosine (m6A)- containing RNAs, and regulates mRNA stability (PubMed:24284625, PubMed:26046440, PubMed:26318451). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing (PubMed:24284625, PubMed:22575960, PubMed:25412658, PubMed:25412661). Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT and ribonuclease P/MRP complexes, depending on the context (PubMed:24284625, PubMed:26046440, PubMed:27558897, PubMed:30930054). M6A-containing mRNAs containing a binding site for RIDA/HRSP12 (5'-GGUUC-3') are preferentially degraded by endoribonucleolytic cleavage: cooperative binding of RIDA/HRSP12 and YTHDF2 to transcripts leads to recruitment of the ribonuclease P/MRP complex (PubMed:30930054). Other m6A-containing mRNAs undergo deadenylation via direct interaction between YTHDF2 and CNOT1, leading to recruitment of the CCR4-NOT and subsequent deadenylation of m6A- containing mRNAs (PubMed:27558897). Required maternally to regulate oocyte maturation: probably acts by binding to m6A-containing mRNAs, thereby regulating maternal transcript dosage during oocyte maturation, which is essential for the competence of oocytes to sustain early zygotic development. Also involved in hematopoietic stem cells specification by binding to m6A-containing mRNAs, leading to promote their degradation (PubMed:30065315). Also acts as a regulator of neural development by promoting m6A-dependent degradation of neural development-related mRNA targets. Regulates circadian regulation of hepatic lipid metabolism: acts by promoting m6A-dependent degradation of PPARA transcripts (PubMed:30428350). Regulates the innate immune response to infection by inhibiting the type I interferon response: acts by binding to m6A-containing IFNB transcripts and promoting their degradation (PubMed:30559377). Also acts as a promoter of cap-independent mRNA translation following heat shock stress: upon stress, relocalizes to the nucleus and specifically binds mRNAs with some m6A methylation mark at their 5'-UTR, protecting demethylation of mRNAs by FTO, thereby promoting cap-independent mRNA translation (PubMed:26458103). [The UniProt Consortium]
Schlagworte: Anti-CLL-associated antigen KW-14, Anti-Renal carcinoma antigen NY-REN-2, Anti-High-glucose-regulated protein 8, Anti-YTH domain-containing family protein 2
Hersteller: Bethyl Laboratories
Hersteller-Nr: A700-297

Eigenschaften

Anwendung: WB, FC
Antikörper-Typ: Monoclonal
Klon: BLR297M
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human, mouse
Format: Antigen Affinity Purified

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-YTHDF2 Recombinant Monoclonal"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen